T-cell receptor-CD3 epsilon complex (TCR-CD3e)

The CD3ε-containing T-cell receptor (TCR) complex is a critical multi-subunit protein assembly found on the surface of T lymphocytes (UniProt P07766) [1]. It is composed of the antigen-recognizing TCR heterodimer associated with the CD3 signaling complex, which includes the epsilon (ε), delta (δ), gamma (γ), and zeta (ζ) chains (NCBI Gene 916) [2]. The CD3ε subunit plays a pivotal role in signal transduction by utilizing its cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) to recruit kinases like ZAP-70 upon antigen binding (StatPearls) [3]. This target is central to modern immunotherapy, particularly in the development of bispecific T-cell engagers (BiTEs) that redirect T-cell cytotoxicity toward malignant cells by binding CD3ε and a tumor-associated antigen simultaneously (Nature Reviews Drug Discovery) [4]. Beyond oncology, CD3ε is targeted by immunosuppressive agents to prevent organ transplant rejection or to treat autoimmune conditions like type 1 diabetes by modulating T-cell activity (DrugBank DB06572) [5]. Therapeutic engagement of CD3ε often leads to the rapid release of inflammatory cytokines, necessitating careful management of cytokine release syndrome (CRS) (PubMed PMC7323749) [6]. Overall, the CD3ε-containing TCR complex serves as a master switch for the adaptive immune system, making it a high-value target for both immune activation and suppression.

Other names

CD3 epsilonCD3eT-cell surface glycoprotein CD3 epsilon chainT-cell surface antigen T3/Leu-4 epsilon chainT3ETCRE

Drugs targeting the CD3ε-containing TCR complex primarily act through T-cell redirection or T-cell modulation. Bispecific antibodies bind to CD3ε on T-cells and a specific antigen on target cells, creating a cytolytic synapse that triggers MHC-independent tumor cell killing (Nature Reviews Drug Discovery) [4]. Monoclonal antibodies can also bind CD3ε to induce T-cell depletion or TCR modulation, suppressing autoimmune responses or preventing transplant rejection (DrugBank DB06572) [5].